ja_mageia

Abstract Submission and important dates:
-February 5, 2010: Deadline for abstracts submitted for PLATFORM presentation - Deadline CLOSED!!  Notifications of selected platform presentations will be sent via email by on March 11th. 2010
-EXTENDED to March 12, 2010: Deadline for abstracts submitted for POSTER presentation.
-Early April 2010: Notifications of selected platform and poster presentations will be announced via email.                                                               
Abstract Submission Policy & Guidelines Statement of Purpose
The Abstract Submission Policy & Guidelines are intended to:
i) Ensure that the Children’s Tumor Foundation is able to report to our constituents (those with NF, their families, our donors, and the larger scientific & medical community who may be unable to attend the NF Conference) on progress highlights reported at the NF Conference, and
ii) Provide those investigators who are presenting data at the NF Conference with an opportunity specify what information from their presentations they are comfortable to have disclosed & distributed in any public reports of the NF Conference emerging from the Foundation for the above purpose.

Abstract Format 
All submitted abstracts must meet the following format:
a) All text should be in 12 point Arial font

b) Abstracts SHOULD NOT EXCEED 400 WORDS or ONE PAGE (including author & affiliation information, and references).

c) Provide the presenting author, affiliation and abstract title as follows on the top right of the abstract, bolded:

Title of Abstract: Bold Text

Presenting Author (including degree, MD, Ph.D. etc.): Bold Text
Institution/University: Regular Font, Italicize

d) List all additional authors on the bottom after the abstract text:

e.g. Full List Authors: Joe Blogs MD, University of Tumors; Jane White Ph.D., George Washington University, John Smith MD, Ph.D., Institute of Medical Research, Mary Lee, MD, Jones University

e) Where scientific abbreviations are used, please include the full wording the first time this is used and the abbreviation thereafter. Please do not include Greek or other symbols but use the longhand version of the word (e.g. alpha, beta, delta).

f) Please indicate the granting agency & mechanism whose fiscal support that made the research possible at the end of the abstract.

g) The Name of file should be labeled with the presenting author’s name as follows: Last Name, First Name

If abstracts received do not meet the above requirements, CTF reserves the right to disqualify any abstract.

Posters 
-The dimensions of all posters should be 4 ft. H X 6 ft. L
-Please note that your poster may not exceed these dimensions.
-Tacks will be available.
-Clinical poster presenters will be by their posters on Sunday, June 6, 2010,  2:30 – 4:30PM.
-Basic research poster presenters will be by their posters on Monday, June 7, 2010, 7:30 - 9:30PM.
-All posters will be available for viewing from Saturday, June 5 to Tuesday, June 8.

Please read carefully IMPORTANT NOTES below about your abstract, poster or presentation at the 2010 NF Conference.
1. ALL abstracts accepted for the 2010 NF Conference will be printed in a Program and Abstract Book for distribution to meeting attendees.
2. The Program and Abstract Book will be made available online at www.ctf.org early June prior to the 2009 NF Conference.
3. A meeting report after the Conference for publication in Children's Tumor Foundation quarterly NF NewsLetter and Research E-NewsBlast. If your presentation or poster is mentioned in this report you will have the opportunity to review and request edits to this information prior to report publication.
4. Your abstract, poster and presentation at the NF Conference constitute public disclosure. For more information on public disclosure as it relates to future publications & patent filings from your research, you may wish to speak with your institution’s Technology Transfer/Patenting & Licensing Office.

Please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it if you have questions. This email address is being protected from spam bots, you need Javascript enabled to view it